Institutional investors control 2.28% of the outstanding shares in PURE. This represents a greater percentage of ownership than at almost any other company in the Medical Specialties industry. Additionally, during the quarter ended April 2016, these large investors purchased a $237.0 thousand.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOLDMAN CAPITAL MANAGEMENT, INC. Bought 237.0 Thousand shares of PURE Biosciences Inc